68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
Status:
Completed
Trial end date:
2021-09-27
Target enrollment:
Participant gender:
Summary
This phase II trial studies the impact of 68GA-PSMA-11 positron emission tomography
(PET)/computed tomography (CT) scan on treatment strategies for patients with prostate
cancer. Diagnostic imaging procedures, such as 68GA-PSMA-11 PET/CT scan, may help doctors
plan the best treatment for prostate cancer.